ERBB2 and neoplasm: Concurrently, immune checkpoint inhibition remodels the tumor microenvironment, enabling cytokines—such as IFN-γ and TNF-α secreted by CD8+ T cells, NK cells, and macrophages—to exert dual regulatory effects on HER2 expression (33).